It's the OTC, nothing is justified. Look at tsnp.-- now 5.2 billion marker cap. They did around 100K last year. Divide 5.2 Billion by 100 thousand. Yes, it's 52000 times revenue to current market cap. How can you justify investing in a stock that's market cap is 52,000 times revenue. APRU is at a bargain if they continue to grow. The OTC is based on hopes and dreams. Some come to fruition and some fade away like "coho" last year. APRU has a growing business and an excellent product. Sub penny is a gift for all us investors. GLTA